ESMO Breast Cancer 2022, Berlin, Germany

Invitrocue Chief Scientific Officer, Dr. Zahra Dantes, will be presenting our latest findings on our current validation study regarding breast cancer at ESMO Breast Cancer 2022, 3-5 May, in Berlin.

“Breast Cancer Organoids Mimic Disease Heterogeneity, Allow High-Throughput Drug Screening, and Show Correlation with Clinical Response” #202, Wednesday, 4 May, from 12:15 to 13:00 CEST.

Visit to register your interest and access the virtual platform and live streaming of the session.